Preliminary results have been obtained on the second phase of the clinical trials for the Normogen preparation. Stabilization of the tumor process with positive dynamics was observed for 80% of the patients who have various types of cancerous diseases.
details >     


At present clinical trials of the Normogen drug are carried out by the Kazakh Scientific Research Institute of Oncology and Radiology.

details >     


Report of Kazakhstan Scientific and Research Institute of Oncology and Radiology of the 1st phase of clinical trial of immunobiological, antitumoral drug Normogen
details >     
eXTReMe Tracker

22.11.2006
An Agreement on carrying out of the second phase of Clinical Trials of the drug "Normogen" is concluded with Kazakhstan Scientific and Research Institute of Oncology and Radiology.

10.07.2006
Presented report of the 1st phase of clinical trial of drug "Normogen".


01.05.2006
The first phase of the Clinical Trials of Normogen in Kazakh Scientific and Research Institute of Oncology and Radiology was accomplished on May 1, 2006. The preparation Normogen was accepted as non-toxic, free of any adverse effect and safe for use.

24.01.2006
The Clinical Trials of the preparation Normogen were started in Kazakh Scientific and Research Institute of Oncology and Radiology.



















































   
2005 (c) Copyright Real Med Company. Все права защищены.